| Sustained Virologic Suppression After Discontinuation of Long-acting Cabotegravir/Rilpivirine : A Two-case Series Highlighting Unexpected Heterogeneity in Pharmacokinetics and Viral Control | Open forum infectious diseases |  | | 2026 | 8 | 12 |
|
| Types of Myocardial Infarction in People With HIV in Switzerland | Open forum infectious diseases | | | 2025 | 17 | 86 |
|
| Leukocyte count and new-onset diabetes mellitus in people with HIV : A longitudinal study | HIV medicine | | | 2025 | 26 | 20 |
|
| Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression : Results Through Week 144 of the SIMPL'HIV Trial | Open forum infectious diseases | | | 2024 | 16 | 109 |
|
| Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy : the SIMPL'HIV open-label, factorial randomised controlled trial | Swiss medical weekly | | | 2024 | 25 | 100 |
|
| Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant | Open forum infectious diseases | | | 2023 | 96 | 156 |
|
| Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial | British journal of clinical pharmacology |  | | 2021 | 231 | 0 |
|
| Viral Infections and Cutaneous Drug-Related Eruptions | Frontiers in pharmacology | | | 2021 | 218 | 275 |
|
| Caring for people living with HIV during the global coronavirus disease 2019 pandemic | AIDS | | | 2021 | 260 | 0 |
|
| Prophylaxis for COVID-19: a systematic review | Clinical microbiology and infection | | | 2021 | 100 | 140 |
|
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | | | 2021 | 658 | 231 |
|
| Possible link between anosmia and COVID-19: sniffing out the truth | European Archives of Oto-Rhino-Laryngology | | | 2020 | 207 | 213 |
|
| Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial | PLoS medicine | | | 2020 | 237 | 275 |
|
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | | | 2020 | 285 | 124 |
|
